Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2018-11-02

FDA Approved: IRBESARTAN — Supplemental Application (Hisun Pharmaceuticals USA Inc.)

View source ↗

Summary

The FDA approved a supplemental application for IRBESARTAN by Hisun Pharmaceuticals USA Inc. The approval indicates changes related to the approved product, pot…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Irbesartan (irbesartan)

Snippet

SUPPL AP for IRBESARTAN (IRBESARTAN)